SCHEMBL7877459

SCHEMBL7877459

CN(C(=N)N)C(=O)c1cc2cc(OCc3ccccc3)ccc2[nH]1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.66
ALDH1A1 P00352 1/20 0.66
CYP1A2 P05177 1/20 0.66
CYP2C9 P11712 1/20 0.66
HPGD P15428 1/20 0.66
SRD5A2 P31213 1/20 0.66
HSD17B10 Q99714 1/20 0.66
PDGFRB P09619 4/20 0.62
PDGFRA P16234 4/20 0.62
FLT3 P36888 1/20 0.59
CFD P00746 1/20 0.57
MC4R P32245 2/20 0.52
HDAC1 Q13547 1/20 0.50
HDAC2 Q92769 1/20 0.50
MC5R P33032 1/20 0.50
MC3R P41968 1/20 0.50
ATM Q13315 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7873338 0.99 KDM4E (0.65) KDM4EALDH1A1CYP1A2CYP2C9HPGD
Hydrochloric Acid SCHEMBL7877487 0.91 FLT3 (0.58) KDM4EALDH1A1CYP1A2CYP2C9HPGD
Hydrochloric Acid SCHEMBL7884870 0.84 PDGFRB (0.57) KDM4EALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL6089719 0.83 KDM4E (0.81) KDM4EALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL7877993 0.82 FLT3 (0.48) KDM4EALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL7877731 0.82 MEN1 (0.48) KDM4EALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL7877868 0.82 PDGFRB (0.62) KDM4EALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL7878027 0.82 MEN1 (0.48) KDM4EALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL7877889 0.81 MEN1 (0.50) KDM4EALDH1A1CYP1A2CYP2C9HPGD
Hydrochloric Acid SCHEMBL7880952 0.81 PDGFRB (0.60) KDM4EALDH1A1CYP1A2CYP2C9HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0622356-B1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMA (JP) 1998-07-01 EP disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed
EP-0622356-A1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-02 EP disclosed